Realigning resources to focus on clinical advancement of Selected TIL therapyReducing employee headcount by approximately 60%Streamlining operations with cash runway…
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, approved for…
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with…
GUANGZHOU, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an…
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in…
LUND, SE / ACCESSWIRE / October 11, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced new…
Event Draws 100+ Health Systems for 40+ Sessions Focused on Enhancing the Patient Experience Through Technology and Breaking Down Barriers…
New MammoScreen® AI delivers a comprehensive suite of features including breast density and pre-reporting, creating the ultimate radiologist companion. PARIS…
REDMOND, Wash., Oct. 10, 2024 /PRNewswire/ -- On Thursday, Microsoft Corp. is unveiling several Microsoft Cloud for Healthcare innovations that…
Chuck Suitor will support ColorTokens continued expansion in healthcare industry SAN JOSE, Calif., Oct. 10, 2024 /PRNewswire/ -- ColorTokens Inc.,…